COMMUNIQUÉ DE PRESSE
News
-
-
COMMUNIQUÉ DE PRESSE
Xenetic Biosciences, Inc. Enters into Clinical Trial Services Agreement with PeriNess Ltd. to Accelerate Development of DNase I Oncology Program
Xenetic Biosciences partners with PeriNess to advance clinical proof-of-concept studies for systemic DNase I treatment in pancreatic and colorectal cancers. Collaboration aims to leverage expertize and improve therapeutic responses -
COMMUNIQUÉ DE PRESSE
EQS-Adhoc: Marinomed Biotech AG resolves second capital increase excluding statutory subscription rights by issuing 83,750 no-par value bearer shares at an issue price of EUR 8 per share
Marinomed Biotech AG resolves second capital increase by issuing 83,750 bearer shares at EUR 8 per share, excluding subscription rights -
-
-
COMMUNIQUÉ DE PRESSE
ZenaTech Plans to Disrupt the Land Survey Industry With Drones, Signs LOI for Land Survey Company Acquisition
ZenaTech signs LOI to acquire land survey company, aims to revolutionize industry using drones for speed, accuracy, and innovation. Strategy similar to Uber's disruption of the taxi industry -
-
-
COMMUNIQUÉ DE PRESSE
EUROPLASMA: Information relative au nombre total de droits de vote et d’actions composant le capital au 30 novembre 2024
EUROPLASMA communique le nombre total de droits de vote et d'actions en circulation au 30 novembre 2024. Détails conformément aux réglementations financières en vigueur -
